Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice

Regulatory Toxicology and Pharmacology

Volumn 54, Issue 2, 2009, Pages 114-117

  Arbo, Marcelo Dutra ^a   Schmitt, Gabriela Cristina ^a   Limberger, Mariana Fagundes ^a   Charão, Mariele Feiffer ^b   Moro, Ângela Maria ^b   Ribeiro, Gianine Lima ^b   Dallegrave, Eliane ^c   Garcia, Solange Cristina ^a   Leal, Mirna Bainy ^d   Limberger, Renata Pereira ^a  

^a Faculdade de Farmacia   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c Fundacao Estadual de Producao   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Citrus aurantium; Oxidative stress; p Synephrine; Subchronic toxicity

Indexed keywords

BIOLOGICAL MARKER; CITRUS AURANTIUM EXTRACT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OXEDRINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC TOXICITY; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SOUR ORANGE; SUBCHRONIC TOXICITY; WEIGHT REDUCTION;

ANIMALS; ANTI-OBESITY AGENTS; BIOLOGICAL MARKERS; CATALASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED STRAINS; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; SYNEPHRINE; TOXICITY TESTS, CHRONIC;

ANIMALIA; CITRUS AURANTIUM; MUS;

EID: 66049159732     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2009.03.001     Document Type: Article

References (29)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
2. Arbo M.D., Franco M.T., Larentis E.R., Garcia S.C., Sebben V.C., Leal M.B., Dallegrave E., and Limberger R.P. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats. Arch. Toxicol. 83 (2009) 95-99
3. Arbo M.D., Larentis ER., Linck V.M., Aboy A.L., Pimentel A.L., Henriques A.T., Dallegrave E., Garcia S.C., Leal M.B., and Limberger R.P. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine. Food Chem. Toxicol. 46 (2008) 2770-2775
4. Avula B., Upparapalli S.K., Navarrete A., and Khan I.A. Simultaneous quantification of adrenergic amines and flavonoids in C. aurantium, various Citrus species, and dietary supplements by liquid chromatography. J. AOAC Int. 88 (2005) 1593-1606
5. Bouchard N.C., Howland M.A., Greller H.A., Hoffman R.S., and Nelson L.S. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine. Mayo Clin. Proc. 80 (2005) 541-545
6. Brown J.M., and Yamamoto B.K. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol. Ther. 99 (2003) 45-53
7. Bui L.T., Nguyen D.T., and Ambrose P.J. Blood pressure and heart rate effects following a single dose of bitter orange. Ann. Pharmacother. 40 (2006) 53-57
8. Calapai G., Firenzuoli F., Saitta A., Squadrito F., Arlotta M.R., Constantino G., and Inferrera G. Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report. Fitoterapia 70 (1999) 586-592
9. De Smet P.A.G.M. Health risks of herbal remedies: an update. Clin. Pharmacol. Ther. 76 (2004) 1-17
10. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 (1959) 70-77
11. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
12. Firenzuoli F., Gori L., and Galapai C. Adverse reaction to an adrenergic herbal extract (Citrus aurantium). Phytomedicine 12 (2005) 247-248
13. Frey B.N., Valvassori S.S., Gomes K.M., Martins M.R., Dal-Pizzol F., Kapczinski F., and Quevedo J. Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res. 1097 (2006) 224-229
14. Fugh-Bergman A., and Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp. Biol. Med. 299 (2004) 698-704
15. Gange C.A., Madias C., Felix-Getzik E.M., Weintraub A.R., and Mark III N.A. Variant angina associated with bitter orange in a dietary supplement. Mayo Clin. Proc. 84 (2006) 545-548
16. Grotto D., Santa Maria L.D., Boeira S., Valentini J., Charão M.F., Moro A.M., Nascimento P.C., Pomblum V.J., and Garcia S.C. Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection. J. Pharm. Biomed. Anal. 47 (2007) 619-624
17. Gul M., Kutay F.Z., Temocin S., and Hanninen O. Cellular and clinical implications of glutathione. Indian J. Exp. Biol. 38 (2000) 625-634
18. Haller C.A., and Benowitz N.L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N. Engl. J. Med. 343 (2000) 1833-1838
19. Jordan S., Murty M., and Pilon K. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions. CMAJ 171 (2004) 993-994
20. Ko H.C., Wang Y.H., Liou K.T., Chen C.M., Chen C.H., Wang W.Y., Chang S., You H.C., Chen K.T., Chen C.F., and Shen Y.C. Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. Eur. J. Pharmacol. 555 (2007) 211-217
21. Kovacic P., and Cooksy A.L. Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species. Med. Hypotheses 64 (2005) 357-366
22. Lewis R.W., Billington R., Debryune E., Gamer A., Lang B., and Carpanini F. Recognition of adverse and nonadverse effects in toxicity studies. Toxicol. Pathol. 30 (2002) 66-74
23. McCord J.M., and Fridovich I. Superoxide dismutase, an enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244 (1969) 6049-6055
24. Michiels C., Raes M., Toussaint O., and Remacle J. Importance of Se-glutathione peroxidase, catalase and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17 (1994) 235-248
25. Nozal M.J., Bernal J.L., Toribio L., Marinero P., Moral O., Manzanas I., and Rodriguez E. Determination of glutathione, cysteine and N-acetylcysteine in rabbit eye tissues using high-performance liquid chromatography and post-column derivatization with 5-5′-dithio-bis(2-nitrobenzoic acid). J. Chromatogr. A 778 (1997) 347-353
26. Nykamp D.L., Fackih M.N., and Compton A.L. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement. Ann. Pharmacother. 38 (2004) 812-816
27. Paglia D.E., and Valentine W.N. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70 (1967) 158-169
28. Shankaran M., Yamamoto B.K., and Gudelsky G.A. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse 40 (2001) 55-64
29. Yamamoto B.K., and Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287 (1998) 107-114